According to Evolent Health's latest financial reports the company has a price-to-book ratio of 2.68.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2022-12-31 | 3.31 | -7.3% |
2021-12-31 | 3.57 | 63.43% |
2020-12-31 | 2.18 | 164.86% |
2019-12-31 | 0.8240 | -37.95% |
2018-12-31 | 1.33 | 51.26% |
2017-12-31 | 0.8780 | 2.91% |
2016-12-31 | 0.8531 | 58.68% |
2015-12-31 | 0.5376 | |
2014-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
![]() National Healthcare
NHC | 1.16 | -56.69% | ๐บ๐ธ USA |
![]() Global Cord Blood CORBF | 0.2140 | -92.03% | ๐ญ๐ฐ Hong Kong |
![]() Graham Holdings GHC | 0.7023 | -73.84% | ๐บ๐ธ USA |